NEWS

NEWS

Press Releases NEWS PAGE COMPANY INDEX Press Releases

 

ajo.gif (628 bytes)ValiGen
ValiGen is a privately held European-American biotechnology company deriving commercial value from its integrated suite of genomics and Genoplasty technologies and proprietary databases by producing novel human therapeutics and plants with desirable traits. Agricore joins today ValiGen's other prestigious partners in the pharmaceutical and biotechnology industries. 
Led by an industry-experienced management team and entrepreneurial board of directors, ValiGen has operating labs and offices in: Paris, France; Berlin, Germany; Newtown, Penn. and San Diego.
December 01

ValiGen N.V. announces management changes (4031)

May 01

ValiGen and Agricore form alliance to develop and market specialty canola products (3530)


February 00

ValiGene and Kimeragen in merger to create an integrated functional genomics company - Combined technologies provide a seamless system for target identification, validation and product development in human healthcare and agriculture (2571)


July 99

Kimeragen annnounces publication of successful results of chimeraplasty, a new gene-alteration technique, in plants (1999)

May 99

Burrill & Company announce completion of a private financing of Kimeragen, Inc. (N1811)


December 98

Kimeragen and AgriBioTech announce collaboration to improve turfgrass and forage seed (N1410)


October 97

Kimeragen, Inc. licenses "chimeraplasty" to AgrEvo - Agreement covers technology for plant gene repair, replacement and modification (2001)

March 97

Pioneer Hi-Bred and Kimeragen sign research collaboration (2000)
.

300 Pheasant Run - Newtown PA 18940 - USA
E-mail: info@kimeragen.com - Phone: +1 (215) 504 4444 - Fax: +1 (215) 504 4545

 

Copyright © 1998 SeedQuest - All rights reserved